Mandaviya review essential medicines, drugs status with Pharma Companies

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Medlarge Bureau Top News, COVID-19 Updates, Latest

Amid sudden global spike in COVID cases, Union health minister Mansukh Mandaviya on Thursday reviewed the status, adequacy of COVID management drugs and production capacities with representatives of pharma companies through a VC, here today.

The virtual meeting was held to effectively handle any situation arises in view of the spike in COVID19 cases in some countries worldwide.

Through a presentation, the Union Minister was briefed regarding the evolving global scenario. “India’s pharmaceutical industry is robust, resilient and responsive. It is due to their strength that we could not only meet our down demand during the pandemic, but also be in a position to supply medicines to 150 countries”, Mandaviya said.

He stressed that it has been achieved without any fall in quality and no hike in the price of the medicines. The pharma companies were asked to keep a close watch on the global supply chain scenario. They were also asked to closely monitor production and availability of APIs as well as formulations of essential medicines for COVID management.

The health minister asked the Pharma company to ensure adequate stocks and availability of all drugs including COVID drugs in the supply chain up to the retail level. The pharma companies hailed the timely review meeting and assured their continued support.

The Pharma company assured to manage the supply chain of COVID drugs.